Stock A038530 KBIO COMPANY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials KBIO COMPANY Inc.

Equities

A038530

KR7038530002

Drug Retailers

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 10/05/2024 am IST 		5-day change 1st Jan Change
281 KRW +0.36% Intraday chart for KBIO COMPANY Inc. -1.06% 0.00%
2023 Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd. CI

Valuation

Fiscal Period: December 2018 2021 2022 2023
Capitalization 1 24,211 1,07,381 36,903 32,455
Enterprise Value (EV) 1 22,550 69,907 2,335 -20,945
P/E ratio -2.98 x -5.11 x -4.77 x -2.26 x
Yield - - - -
Capitalization / Revenue 4.24 x 12.3 x 1.1 x 1.19 x
EV / Revenue 3.95 x 8.01 x 0.07 x -0.77 x
EV / EBITDA -20.8 x -15.8 x 5.32 x 167 x
EV / FCF -2.11 x - 1.17 x 4.27 x
FCF Yield -47.5% - 85.4% 23.4%
Price to Book 1.21 x 1.7 x 0.55 x 0.51 x
Nbr of stocks (in thousands) 17,110 83,241 91,799 1,15,497
Reference price 2 1,415 1,290 402.0 281.0
Announcement Date 07/08/20 20/03/23 20/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2021 2022 2023
Net sales 1 5,708 8,722 33,648 27,325
EBITDA 1 -1,086 -4,413 439.1 -125.7
EBIT 1 -1,297 -5,087 -152.5 -616.8
Operating Margin -22.73% -58.33% -0.45% -2.26%
Earnings before Tax (EBT) 1 -4,472 -16,585 -7,767 -11,817
Net income 1 -4,380 -19,466 -7,665 -12,674
Net margin -76.74% -223.18% -22.78% -46.38%
EPS 2 -475.0 -252.3 -84.23 -124.4
Free Cash Flow 1 -10,704 - 1,994 -4,900
FCF margin -187.52% - 5.93% -17.93%
FCF Conversion (EBITDA) - - 454.22% -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 07/08/20 20/03/23 20/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 1,661 37,474 34,569 53,399
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -10,704 - 1,994 -4,900
ROE (net income / shareholders' equity) -35.1% - -12% -12.1%
ROA (Net income/ Total Assets) -2.52% - -0.11% -0.34%
Assets 1 1,73,920 - 68,31,641 37,05,976
Book Value Per Share 2 1,174 758.0 728.0 548.0
Cash Flow per Share 2 735.0 519.0 436.0 413.0
Capex 1 7,253 93.4 15.6 7.95
Capex / Sales 127.06% 1.07% 0.05% 0.03%
Announcement Date 07/08/20 20/03/23 20/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
KBIO COMPANY INC. Stock KBIO COMPANY Inc.
0.00% 23.7M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-34.16% 14.83B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-25.06% 12.04B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-26.42% 6.52B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+14.96% 6.44B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.05% 6.15B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-2.48% 4.64B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+60.00% 4.62B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-8.10% 3.93B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-11.16% 3.49B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. A038530 Stock
  4. Financials KBIO COMPANY Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW